Trial intelligence / Profile preview

Intrapleural Methylprednisolone for ARDS with MODS

NCT01423864Phase 2Completed

Sponsor
National Taiwan University Hospital
Start
Jun 2005
Primary completion
Jun 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone injection in acute respiratory distress syndrome (ARDS), multiple organ dysfunction syndrome (MODS), sponsored by National Taiwan University Hospital. Started Jun 2005; status: completed.

02

Drugs

methylprednisolone injection
03

Conditions

acute respiratory distress syndrome (ARDS)multiple organ dysfunction syndrome (MODS)

Beyond the preview

Go deeper on NCT01423864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01423864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call